2-8 CELLSIUS
Live / Registered — Registered and renewed (as of 03 Nov 2023)
What this means for you
Registered since 22 Apr 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Apr 2024).
Record
- Serial number
- 85679448
- Registration number
- 4518483
- Mark type
- Stylized text
- Filed
- 17 Jul 2012
- Published for opposition
- 30 Jul 2013
- Registered
- 22 Apr 2014
- Next maintenance due
- 22 Apr 2024
- Attorney of record
- John Pickerill
Goods and services
- Class 005 — Pharmaceuticals: Cell therapy nutrients, namely, solutions for medical and clinical use in storing, preserving and transporting cells
Owner
- Protide Pharmaceuticals, Inc., Lake Zurich, IL, US
- Protide Pharmaceuticals, Inc., Lake Zurich, IL, US
- Protide Pharmaceuticals, Inc., Lake Zurich, IL, US
Prosecution history
- 03 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 03 Nov 2023 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 03 Nov 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 21 Oct 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Apr 2023 — TEAS SECTION 8 & 9 RECEIVED
- 22 Apr 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 07 Jun 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 07 Jun 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 07 Jun 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Apr 2019 — TEAS SECTION 8 & 15 RECEIVED
- 22 Apr 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Apr 2014 — REGISTERED-PRINCIPAL REGISTER
- 20 Mar 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Mar 2014 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 19 Mar 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED